Attention Medical Professionals: PJSC Kraspharma launches a new medicinal product — Fosfomycin, powder for solution for intravenous administration, available in 2 g and 4 g dosages.

01.04.2018

PJSC "Kraspharma" Expands Its Antimicrobial Portfolio with Clinically Significant New Dosages of Fosfomycin

PJSC Kraspharma has launched Fosfomycin, powder for solution for intravenous administration, now available in two new dosages — 2 g and 4 g — addressing the current clinical demands for optimized dosing in the treatment of severe infections caused by resistant pathogens.

These new dosage forms are tailored to meet contemporary therapeutic protocols, which often require intravenous administration of 12 g to 24 g per day. Fosfomycin is known for its broad therapeutic window and excellent tolerability, even at high daily doses.

The availability of dose-adjusted formats improves the ease of preparation and administration, reduces the risk of dosing errors, and enhances treatment precision in hospital settings.

A detailed description of Fosfomycin 2 g and 4 g for IV use is available via the following link >>
This website uses cookies and similar technologies to assist with navigation, enhance your user experience, and analyze usage of our products and services.
I agree